Huntington's Disease Research

Huntington's disease is a neurodegenerative disease characterized by cognitive decline and motor dysfunction. It is a genetic disorder which results in the production of mutant huntingtin protein (mHtt). This protein aggregates in the cell cytoplasm and nucleus, affecting cellular function.

Huntington's Disease Research Products Targets

Products for Huntington's Disease Research - Page 37

  1. Cat.No. Product Name Information/Activity
  2. BCC1780 MTEP hydrochloride MTEP hydrochloride is a potent, selective and non-competitive mGlu5 antagonist with an IC50 of 5 nM and a Ki of 16 nM. MTEP hydrochloride produces antiparkinsonian-like effects. MTEP hydrochloride chemical structure
  3. BCC6119 NPS 2390 226878-01-9 NPS 2390 chemical structure
  4. BCC6895 PHCCC PHCCC is a Group I metabotropic glutamate receptor antagonist with EC 50 of 6 uM and a positive allosteric modulator of mGluR4. Also as a potent to antagonism for mGluR2 and mGluR8. PHCCC chemical structure
  5. BCC6971 SIB 1757 31993-01-8 SIB 1757 chemical structure
  6. BCC7682 YM 202074 299900-84-8 YM 202074 chemical structure
  7. BCC5956 YM 230888 446257-23-4 YM 230888 chemical structure
  8. BCC7366 YM 298198 hydrochloride 1216398-09-2 YM 298198 hydrochloride chemical structure
  9. BCC7365 Desmethyl-YM 298198 1177767-57-5 Desmethyl-YM 298198 chemical structure
  10. BCC6171 ADX 10059 hydrochloride Negative allosteric modulator at mGlu<sub>5</sub> ADX 10059 hydrochloride chemical structure
  11. BCC7610 CDPPB 781652-57-1 CDPPB chemical structure

Items 361 to 370 of 465 total